490 related articles for article (PubMed ID: 18300708)
1. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin in the treatment of dystonias--a hospital based study.
Gupta M; Singh G; Khwaja G
J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
[TBL] [Abstract][Full Text] [Related]
4. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
5. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
[TBL] [Abstract][Full Text] [Related]
6. What is new in the era of focal dystonia treatment? Botulinum injections and more.
Cetinkaya A; Brannan PA
Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237
[TBL] [Abstract][Full Text] [Related]
7. Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A.
Bechara FG; Sand M; Achenbach RK; Sand D; Altmeyer P; Hoffmann K
Dermatol Surg; 2007 Aug; 33(8):924-7. PubMed ID: 17661934
[TBL] [Abstract][Full Text] [Related]
8. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
Badarny S; Susel Z; Honigman S
Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
[TBL] [Abstract][Full Text] [Related]
9. Long-term botulinum toxin efficacy, safety, and immunogenicity.
Mejia NI; Vuong KD; Jankovic J
Mov Disord; 2005 May; 20(5):592-7. PubMed ID: 15645481
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
Thussu A; Barman CR; Prabhakar S
Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
[TBL] [Abstract][Full Text] [Related]
11. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
Tan AK
Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review).
Yin S; Stucker FJ; Nathan CO
J La State Med Soc; 2001 Feb; 153(2):92-7. PubMed ID: 11261363
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A in simple motor tics: short-term and long-term treatment-effects.
Rath JJ; Tavy DL; Wertenbroek AA; van Woerkom TC; de Bruijn SF
Parkinsonism Relat Disord; 2010 Aug; 16(7):478-81. PubMed ID: 20034838
[TBL] [Abstract][Full Text] [Related]
15. Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin.
Swartling C; Naver H; Pihl-Lundin I; Hagforsen E; Vahlquist A
J Am Acad Dermatol; 2004 Nov; 51(5):739-45. PubMed ID: 15523352
[TBL] [Abstract][Full Text] [Related]
16. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
Suputtitada A; Phanthumchinda K; Locharernkul C; Suwanwela NC
J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
[TBL] [Abstract][Full Text] [Related]
17. [Results of long term treatment of essential blepharospasm and facial hemispasm with botulinum toxin A].
Ziak P
Cesk Slov Oftalmol; 2004 Jan; 60(1):37-44. PubMed ID: 15011305
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
[TBL] [Abstract][Full Text] [Related]
19. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study.
Bechara FG; Sand M; Altmeyer P; Sand D; Hoffmann K
Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136
[TBL] [Abstract][Full Text] [Related]
20. Treatment of plantar hyperhidrosis with botulinum toxin type A.
Vadoud-Seyedi J
Int J Dermatol; 2004 Dec; 43(12):969-71. PubMed ID: 15569036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
